Stage IVA Prostate Cancer AJCC v8 Withdrawn Phase 2 Trials for Gallium Ga-68 gozetotide (DB16019)

IndicationStatusPhase
DBCOND0109674 (Stage IVA Prostate Cancer AJCC v8)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05034562Gallium-68 PSMA-11 PET in Participants With Prostate CancerDiagnostic